Skip to main content

John Penn Archives

Vision foundation’s longtime support key to Penn’s research efforts

Dec. 9, 2021—  by Nancy Humphrey John S. Penn, PhD, has been named the inaugural holder of the Knights Templar Eye Foundation (KTEF) Directorship in Pediatric Vision Research at the Vanderbilt Eye Institute in honor of his contributions to the foundation and the field of vision research. Penn’s connection with the KTEF, which is committed to supporting...

Read more


Directorships honor VUMC leaders and philanthropic partners

Dec. 2, 2021—Ten Vanderbilt University Medical Center leaders from across the enterprise in clinical care, research, education and administration have been named as holders of endowed directorships.

Read more


Insights on diabetic retinopathy

Jan. 23, 2020—A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

Read more


New targets for diabetic retinopathy

Jan. 21, 2016—Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.

Read more


VUMC’s Penn named president-elect of eye research society

Feb. 12, 2015—John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).

Read more


Meranze, Penn named to new Faculty Affairs roles

Jul. 10, 2014—Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs.

Read more


Penn named to vision group’s scientific advisory panel

Oct. 31, 2013—John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.

Read more


Penn seeks new look at eye disorder

Mar. 7, 2013—John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more